XDL
5156
XOXNET
0140
SCABLE
5170
ALRICH
0079
ANEKA
0226
(Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | 4.01M | -33.11%14.39M | 39.75%21.52M | 60.59%15.4M | 9.59M |
Net profit before non-cash adjustment | --1.82M | -36.40%9.68M | -13.03%15.22M | 70.37%17.5M | --10.27M |
Total adjustment of non-cash items | --2.32M | 38.21%8.44M | 239.32%6.1M | -59.39%1.8M | --4.43M |
-Depreciation and amortization | --1.34M | 40.20%4.75M | 14.10%3.39M | 25.34%2.97M | --2.37M |
-Reversal of impairment losses recognized in profit and loss | ---- | 6,299,900.00%63K | -100.00%1 | --181.58K | --0 |
-Disposal profit | --0 | 37.49%49.54K | 101.02%36.03K | -15,548.35%-3.52M | ---22.49K |
-Net exchange gains and losses | --74K | -255.59%-49.02K | 131.17%31.51K | -380.38%-101.06K | ---21.04K |
-Other non-cash items | --908K | 36.77%3.62M | 16.80%2.65M | 7.73%2.27M | --2.1M |
Changes in working capital | ---131K | -2,063.94%-3.72M | 104.86%189.64K | 23.67%-3.91M | ---5.12M |
-Change in receivables | --173K | -835.80%-3.35M | 162.50%455.18K | 71.64%-728.23K | ---2.57M |
-Change in inventory | ---63K | 773.53%187.1K | 99.10%-27.78K | ---3.08M | --0 |
-Change in payables | ---241K | -136.54%-562.38K | -142.72%-237.75K | 117.47%556.52K | ---3.19M |
-Changes in other current assets | ---- | --0 | --0 | -203.10%-656.08K | --636.38K |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | |||||
Interest received (cash flow from operating activities) | |||||
Tax refund paid | -358K | 9.51%-2.56M | -42.93%-2.83M | -111.91%-1.98M | -932.99K |
Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 |
Operating cash flow | --3.65M | -36.67%11.84M | 39.28%18.69M | 55.06%13.42M | --8.65M |
Investing cash flow | |||||
Net PPE purchase and sale | ---467K | -206.64%-7.68M | -141.95%-2.5M | 1,596.87%5.97M | ---398.58K |
Net business purchase and sale | ---- | --0 | -45.02%424.88K | --772.79K | --0 |
Net investment property transactions | ---- | --0 | --0 | --0 | ---351.91K |
Interest received (cash flow from investment activities) | --154K | 4,520.61%6.05K | --131 | --0 | --0 |
Net changes in other investments | ---- | 98.87%-18.37K | -184.34%-1.63M | ---571.86K | ---- |
Investing cash flow | ---433K | -107.55%-7.69M | -160.06%-3.7M | 921.76%6.17M | ---750.48K |
Financing cash flow | |||||
Net issuance payments of debt | ---9.37M | -5.28%-501.56K | -1,028.21%-476.42K | -104.95%-42.23K | --852.62K |
Net common stock issuance | --0 | ---- | ---- | ---- | ---- |
Increase or decrease of lease financing | ---1.47M | -29.62%-5.72M | -47.77%-4.41M | -30.80%-2.99M | ---2.28M |
Cash dividends paid | ---- | ---- | 80.00%-800K | ---4M | ---- |
Interest paid (cash flow from financing activities) | ---1.11M | -36.90%-3.63M | -16.81%-2.65M | -12.46%-2.27M | ---2.02M |
Net other fund-raising expenses | ---- | ---- | 96.07%-259.26K | -3,844.49%-6.6M | ---167.28K |
Financing cash flow | ---11.95M | -14.56%-9.86M | 45.89%-8.6M | -339.39%-15.9M | ---3.62M |
Net cash flow | |||||
Beginning cash position | --32.39M | 67.10%15.81M | 66.45%9.46M | 307.31%5.68M | --1.4M |
Current changes in cash | ---8.73M | -189.40%-5.71M | 73.11%6.38M | -13.96%3.69M | --4.29M |
Effect of exchange rate changes | ---52K | 231.83%47.06K | -140.12%-35.7K | 3,320.68%88.97K | --2.6K |
End cash Position | --23.62M | -35.80%10.15M | 67.10%15.81M | 66.45%9.46M | --5.68M |
Free cash flow | --3.18M | -75.27%3.92M | 52.38%15.86M | 26.08%10.41M | --8.26M |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.